Insider Trading & Ownership - Vaddi Krishna

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Vaddi Krishna
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-24
Purchase
2023-05-26
4:20 pm
Prelude Therapeutics IncPRLDVaddi Krishna
CEO
1,900$5.1528$9,7902,715,145
(Indirect
Direct)
View
2023-05-23
Purchase
2023-05-25
4:03 pm
Prelude Therapeutics IncPRLDVaddi Krishna
CEO
11,856$5.63$66,7492,713,245
(Indirect
Direct)
View
2022-12-20
Purchase
2022-12-21
4:08 pm
Prelude Therapeutics IncPRLDVaddi Krishna
CEO
19,188$5.1306$98,4462,701,389
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-01
Option Award
2024-03-04
5:59 pm
N/A
2034-02-28
Prelude Therapeutics IncPRLDVaddi Krishna
CEO
425,000$0425,000
(Direct)
View
2023-02-07
Option Award
2023-02-09
4:07 pm
N/A
2033-02-06
Prelude Therapeutics IncPRLDVaddi Krishna
CEO
330,000$0330,000
(Direct)
View
2022-02-15
Option Award
2022-02-17
7:09 pm
N/A
2032-02-14
Prelude Therapeutics IncPRLDVaddi Krishna
CEO
327,900$0327,900
(Direct)
View
2021-12-13
Option Award
2021-12-14
5:36 pm
N/A
N/A
Prelude Therapeutics IncPRLDVaddi Krishna
President, CEO
8,000$12.132,580,722
(Direct)
View
2021-07-20
Option Award
2021-07-22
6:16 pm
N/A
2031-07-19
Prelude Therapeutics IncPRLDVaddi Krishna
President, CEO
285,800$0285,800
(Direct)
View
2020-09-29
Conversion
2020-09-29
8:06 pm
N/A
N/A
Prelude Therapeutics IncPRLDVaddi Krishna
President, CEO
167,229$02,020,948
(Indirect)
View

Ownership
2020-09-24
7:30 pm
N/A
N/A
Prelude Therapeutics IncPRLDVaddi Krishna
President, CEO
0$04,553,094
(Direct)
View